FDA Nod for Teleflex's EZ-Blocker

Teleflex Inc., a global leader in medical devices used in critical care and surgery, recently received notice that the U.S. Food and Drug Administration (:FDA) has granted 510(k) clearance for its Rusch EZ-Blocker Disposable Endobronchial Blocker. The EZ-Blocker Endobronchial Blocker had previously received the European CE Mark approval.

The EZ-Blocker Endobronchial Blocker will enable safer lung isolation and one lung ventilation. Its novel features will enhance standards of care by reducing the risk of dislocation during surgery.

Teleflex’s EZ-Blocker Endobronchial Blocker will enhance its anesthesia portfolio in its largest segment: Critical Care. The approval will also extend the company’s available line of differentiated Rusch and Sheridan brands of endotracheal and endobronchial products.